- Press Releases
- Notices
Press Releases To List
-
- Aug.07.2025Licensing
- Ono Enters into a Definitive Agreement with Seikagaku for Co-development and Marketing Collaboration on Gel-One for the Treatment of Osteoarthritis in Japan
-
- Aug.07.2025Sustainability
- Ono Continues to be Selected for ESG Investment Indexes Adopted by GPIF
-
- Aug.01.2025Management / Finance
- Announcement on Financial Results for FY2025 Q1
-
- Aug.01.2025Corporate
- Notice concerning the Establishment of Ono Global Reinsurance, Inc. as an Overseas Subsidiary (Specified Subsidiary)
-
- Jul.29.2025Sustainability
- ONO Receives Highest A-List Rating in CDP 2024 Report for Climate Change and Water Security Efforts
Notices To List
-
- Aug.04.2025Corporate
- Notice about Posting of the Business Result Meeting for FY2025 Q1 - Script
-
- Jun.20.2025Corporate
- Voting Results (Extraordinary Report) of the 77th Ordinary General Shareholders’ Meeting
-
- Jun.19.2025Corporate
- Notice to Resolutions Passed at The 77th Ordinary General shareholders’ Meeting
-
- Jun.11.2025Corporate
- Notice about Posting of R&D Day - ASCO PROSPECT Study Data Presentation - Script
-
- May.28.2025Corporate
- Notice about Posting of R&D Day - ROMVIMZA - Script
About
We Want to Deliver New Drugs
to the World with a Wish.
For more than 300 years since its foundation in 1717, working for people’s health.
Diseases still unconquered. Patients' wishes still unfulfilled.
ONO, with a wish to meet these medical needs, devotes all its efforts to drug discovery.
